The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)